title: [HTLV and "donating" milk].
abstract: In France, the screening for human T-cell leukemia/ lymphoma virus type 1 and 2 (HTLV-1 and HTLV-2) during the donation of human milk has been carried out from 1992 with the application of the circular DGS 24 November 1992. The screening for antibodies against these viruses is regulated and done systematically during every donation of milk. Breast feeding being the main mode of transmission of the HTLV-1, the last ministerial decree of 25 August 2010 has made the screening test compulsory for the anonymous donation and for the personalized donation (of a mother for her own child) from all women including those affected by the infection. The milk delivered by milk banks is pasteurized (62.5 °C for 30 minutes) before freezing at -18 °C, which inactivates the pathogens. This double means of prevention of the transmission of the HTLV-1 paradoxically seems disproportionate in the absence of any precautionary measure in the case of direct breast-feeding and the use of mother's raw milk. Indeed, in most neonatal intensive care units in maternity hospitals, unpasteurized milk is administered to the neonates without any systematic preliminary testing of the serological HTLV-1 status of the mother. An increased sensitization of the community of the obstetricians, midwives and neonatologists by the Association of the Milk Banks of France (ADLF) and the Société de pathologie exotique could address the issue of screening for HTLV-1 in "donated" milk and breast-feeding.
authors.affiliation: Institut de puériculture et de périnatalogie, Paris, France. ipp.rigourd@free.fr
authors.forename: V
authors.initials: V
authors.lastname: Rigourd
authors.forename: V
authors.initials: V
authors.lastname: Meyer
authors.forename: F
authors.initials: F
authors.lastname: Kieffer
authors.forename: S
authors.initials: S
authors.lastname: Aubry
authors.forename: J-F
authors.initials: JF
authors.lastname: Magny
mesh_terms: D000328:Adult; D001942:Breast Feeding; D015925:Cryopreservation; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D005260:Female; D005602:France; D015490:HTLV-I Infections / Q000517:prevention & control* / Q000635:transmission; D015491:HTLV-II Infections / Q000517:prevention & control* / Q000635:transmission; D006291:Health Policy; D006358:Hot Temperature; D015368:Human T-lymphotropic virus 1 / Q000302:isolation & purification*; D015367:Human T-lymphotropic virus 2 / Q000302:isolation & purification*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008403:Mass Screening / Q000331:legislation & jurisprudence*; D017784:Milk Banks / Q000331:legislation & jurisprudence / Q000592:standards; D008895:Milk, Human / Q000821:virology*; D009035:Mothers; D012189:Retrospective Studies; D014019:Tissue Donors; D038301:Virus Inactivation